Understanding the relationship between female reproductive span and dementia risk
Understanding the relationship between female reproductive span and dementia risk
批准号:
10468823
负责人:
Matthew S Panizzon
金额:
$23.69万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-15 至 2024-03-31
关键词:
AccountingAgeAge at MenarcheAlzheimer&aposs disease related dementiaBindingBiologicalBiological MarkersBrainBreast FeedingContraceptive UsageCost of IllnessDataData AnalysesData AnalyticsData SetDevelopmentDiseaseESR1 geneESR2 geneEarly identificationEnvironmental Risk FactorEstrogensEtiologyEventExposure toFemaleGenesGeneticGenetic RiskGoalsHealthHeritabilityHormone ReceptorHormone replacement therapyHormonesIndividualInterventionKnowledgeLifeLife Cycle StagesLongevityMeasuresMenopauseMethodsNatureOperative Surgical ProceduresOral ContraceptivesPersonsPhenotypePhysiologicalPregnancyPrevalencePrevention strategyProxyPublic HealthRegistriesRelative RisksReproductive HistoryResearchResearch PersonnelRoleSex DifferencesStatistical MethodsStressStructureSurvival AnalysisSymptomsTechniquesTestingTherapeutic InterventionTwin Multiple BirthUnited StatesUnited States National Institutes of HealthWomanWomen&aposs Healthaging brainanalytical methoddementia riskeconomic impactgene environment interactiongenetic analysishealth differenceinnovationinsightmiddle agenovelparitypopulation basedprogramsreproductivereproductive hormonesexyears of life lost
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Despite robust evidence for a sex difference in Alzheimer’s disease and related dementias (ADRD), the
mechanisms behind this difference remain poorly understood. Given that reproductive hormones are a central
determinant of sex differences in brain structure and function, we hypothesize that factors that influence
lifetime reproductive hormone exposure (in particular estrogen exposure) are critical to understanding the
development of ADRD in women. The goal of the proposed study is to utilize existing data from the Swedish
Twin Registry – one of the largest population-based twin registries in the world – in order to understand the
genetic and environmental relationships underlying the association between female reproductive history and
ADRD. In Aim 1 we will use conventional and new data analytic methods to elucidate the degree to which the
association between female reproductive span and ADRD is due to shared genetic and environmental factors.
The genetic analysis of ADRD, and by extension any analysis which seeks to determine the degree of genetic
overlap with ADRD, is complicated by the fact that the relative risk of ADRD varies dramatically by age. We
will develop a genetically-informative survival analysis method to estimate the genetic and environmental
determinants of ADRD, as well as genetic and environmental correlations with reproductive span. In Aim 2, we
will test whether female reproductive span modifies the genetic and environmental determinants of ADRD.
Reproductive hormones like estrogen primarily exert their physiological influence by binding to hormone
receptors, which in turn modulate the expression of downstream genes. We hypothesize that due to this
mechanism, the heritability of ADRD will vary as a function of female reproductive span. In Aim 3, we will
determine how key women’s health factors – oral contraceptive use, parity, surgical menopause, and hormone
replacement therapy – impact the association between reproductive span and ADRD. We hypothesize that
these factors, which are crucial to understanding women’s health across the lifespan, will impact ADRD risk by
modifying the degree of lifetime estrogen exposure. This proposal will advance the field’s understanding of
how female reproductive history contributes to the etiology of ADRD by providing the first genetically-informed
analysis of the relationship between female reproductive span and ADRD conducted in twins, developing
analytic methods that are essential to genetically-informed analysis of ADRD, testing novel hypotheses
regarding whether lifetime estrogen exposure influences the genetic and environmental determinants of ADRD,
and finally determining how factors common to female reproductive history influence the relationship between
reproductive span and ADRD. The NIH has placed a major emphasis on the need for researchers to treat sex
as a biological variable, and to focus on those factors that contribute to sex differences in health and disease.
The proposed study directly confronts this issue by examining the impact of female reproductive history – a
major determinant of women’s health later in life – on ADRD risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the relationship between female reproductive span and dementia risk
-
批准号:10301699
-
项目类别:
-
资助金额:$22.68万
-
财政年份:2021
-
负责人:Matthew S Panizzon
-
依托单位:
Effects of Androgen Deprivation Therapy on Preclinical Symptoms of Alzheimer's Disease
-
批准号:9364864
-
项目类别:
-
资助金额:$65.48万
-
财政年份:2017
-
负责人:Matthew S Panizzon
-
依托单位:
Effects of Androgen Deprivation Therapy on Preclinical Symptoms of Alzheimer's Disease
-
批准号:10176322
-
项目类别:
-
资助金额:$63.19万
-
财政年份:2017
-
负责人:Matthew S Panizzon
-
依托单位:
Testosterone-Androgen Receptor Genetics: Role in Cognitive and Biological Aging
-
批准号:9281627
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2014
-
负责人:Matthew S Panizzon
-
依托单位:
Testosterone-Androgen Receptor Genetics: Role in Cognitive and Biological Aging
-
批准号:8912967
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2014
-
负责人:Matthew S Panizzon
-
依托单位:
Testosterone-Androgen Receptor Genetics: Role in Cognitive and Biological Aging
-
批准号:8750039
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2014
-
负责人:Matthew S Panizzon
-
依托单位:
Testosterone-Androgen Receptor Genetics: Role in Cognitive and Biological Aging
-
批准号:9066056
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2014
-
负责人:Matthew S Panizzon
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: